Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study.
Bocquel S, Soria A, Raison-Peyron N, Badaoui A, Marcant P, Bara C, Giordano-Labadie F, Amsler E, Milpied B, Delaunay J, Darrigade AS, Pralong P, Boulard C, Ferrier Le Bouedec MC, Tauber M, Pasteur J, Valois A, Le Thuaut A, Crépy MN, Bernier C. Bocquel S, et al. Among authors: valois a. J Am Acad Dermatol. 2024 Mar;90(3):512-520. doi: 10.1016/j.jaad.2023.10.029. Epub 2023 Oct 21. J Am Acad Dermatol. 2024. PMID: 37871801
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
Faiz S, Giovannelli J, Podevin C, Jachiet M, Bouaziz JD, Reguiai Z, Nosbaum A, Lasek A, Ferrier le Bouedec MC, Du Thanh A, Raison-Peyron N, Tetart F, Duval-Modeste AB, Misery L, Aubin F, Dompmartin A, Morice C, Droitcourt C, Soria A, Arnault JP, Delaunay J, Mahé E, Richard MA, Schoeffler A, Lacour JP, Begon E, Walter-Lepage A, Dillies AS, Rappelle-Duruy S, Barete S, Bellon N, Bénéton N, Valois A, Barbarot S, Sénéchal J, Staumont-Sallé D; Groupe de Recherche sur l'Eczéma aTopique (GREAT), France. Faiz S, et al. Among authors: valois a. J Am Acad Dermatol. 2019 Jul;81(1):143-151. doi: 10.1016/j.jaad.2019.02.053. Epub 2019 Feb 27. J Am Acad Dermatol. 2019. PMID: 30825533
[Delayed hypersensitivity to anti-tuberculosis drugs. Proposed practical management plan for exanthema: when to stop, which allergological investigations to perform, and how to restart treatment].
Ingen-Housz-Oro S, Assier H, Gener G, Milpied B, Soria A, Bernier C, Descamps V, Tetart F, Staumont-Sallé D, Valeyrie-Allanore L, Valois A, Sassolas B, Bensaid B, Lebrun-Vignes B, Barbaud A; Groupe FISARD de la SFD. Ingen-Housz-Oro S, et al. Among authors: valois a. Ann Dermatol Venereol. 2019 Apr;146(4):313-318. doi: 10.1016/j.annder.2019.01.010. Epub 2019 Mar 21. Ann Dermatol Venereol. 2019. PMID: 30904277 French. No abstract available.
De novo psoriasis in atopic dermatitis patients treated with dupilumab: a retrospective cohort.
Jaulent L, Staumont-Sallé D, Tauber M, Paul C, Aubert H, Marchetti A, Sassolas B, Valois A, Nicolas JF, Nosbaum A; for GREAT Research Group. Jaulent L, et al. Among authors: valois a. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e296-e297. doi: 10.1111/jdv.17050. Epub 2020 Dec 10. J Eur Acad Dermatol Venereol. 2021. PMID: 33232538 No abstract available.
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.
Marcant P, Balayé P, Merhi R, Jendoubi F, Nosbaum A, Raison-Peyron N, Du-Thanh A, Lasek A, Ferrier le Bouedec MC, Tetart F, Valois A, Barbarot S, Soria A, Jachiet M, Staumont-Sallé D; GREAT Research Group. Marcant P, et al. Among authors: valois a. J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e394-e396. doi: 10.1111/jdv.17177. Epub 2021 Mar 5. J Eur Acad Dermatol Venereol. 2021. PMID: 33594731 No abstract available.
Immunosuppressants as steroid-sparing agents for chronic DRESS: four cases.
Ingen-Housz-Oro S, Staumont-Sallé D, Palladini A, Ferries L, Chiaverini C, Valois A, Tieulié N, Bernigaud C, Milpied B. Ingen-Housz-Oro S, et al. Among authors: valois a. Eur J Dermatol. 2021 Aug 1;31(4):576-577. doi: 10.1684/ejd.2021.4103. Eur J Dermatol. 2021. PMID: 34642143 No abstract available.
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice.
Marniquet ME, Seneschal J, Darrigade AS, Staumont-Sallé D, Jachiet M, Nosbaum A, Tauber M, Abasq C, Ferrier Le Bouedec MC, Droitcourt C, Aubert H, Bernier C, Soria A, Raison-Peyron N, Tétart F, Aubin F, Viguier M, Valois A, Kupfer-Bessaguet I, Goronflot T, Barbarot S; Groupe de Recherche sur l’Eczéma Atopique (GREAT). Marniquet ME, et al. Among authors: valois a. Br J Dermatol. 2022 Apr;186(4):733-735. doi: 10.1111/bjd.20883. Epub 2022 Jan 20. Br J Dermatol. 2022. PMID: 34748654 No abstract available.
Multiple cases of sensitization to an antiseptic containing chlorhexidine digluconate/benzalkonium chloride/benzyl alcohol with different profiles of sensitization in adults and children.
Beaumont C, Darrigade AS, Barbaud A, Collet E, Raison-Peyron N, Bourrain JL, Assier H, Giordano-Labadie F, Bara-Passot C, Milpied B, Tétart F, Armingaud P, Castelain F, Benkalfate L, Boulard C, Delaunay J, Mathelier-Fusade P, Pecquet C, Pralong P, Vital-Durand D, Genillier Foin N, Lefèvre MA, Hacard F, Nosbaum A, Pasteur J, Valois A, Vigan M, Ferrier le Bouëdec MC; REVIDAL-GERDA Network. Beaumont C, et al. Among authors: valois a. Contact Dermatitis. 2022 Jul;87(1):62-70. doi: 10.1111/cod.14085. Epub 2022 Mar 29. Contact Dermatitis. 2022. PMID: 35213760
What is the optimal duration for a ROAT? The experience of the French Dermatology and Allergology group (DAG).
Amsler E, Assier H, Soria A, Bara C, Ferrier le Bouëdec MC, Barbaud A, Milpied B, Giordano-Labadie F, Pasteur J, Badaoui A, Valois A, Castelain F, Kurihara F, Castagna J, Boulard C, Bernier C, Leleu C, Marcant P, Crépy MN, Tetart F, Raison-Peyron N; from the Dermatology and Allergy Group of the French Society of Dermatology (DAG). Amsler E, et al. Among authors: valois a. Contact Dermatitis. 2022 Aug;87(2):170-175. doi: 10.1111/cod.14118. Epub 2022 Apr 15. Contact Dermatitis. 2022. PMID: 35383393
86 results